Exelixis | Creditori Commerciali

Prezzo Delle Azioni
43.42
Cambio Giornaliero
0.77 1.81%
Mensile
-0.60%
Annuale
28.96%
Q1 Previsione
40.09




Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Agios Pharmaceuticals USD 19.55M 2.02M 2025-09
Amgen USD 19.64B 1.61B 2025-09
AstraZeneca USD 25.03B 1.04B 2025-09
Bayer EUR 6.38B 343M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Cytokinetics USD 22.08M 46.46M 2025-09
Eisai JPY 80.73B 2.26B 2025-09
Eli Lilly USD 4.26B 186.5M 2025-09
Exelixis USD 25.35M 471K 2025-09
Genmab DKK 6M 2M 2025-09
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Incyte USD 171.92M 1.24B 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
MacroGenics USD 5.94M 1.28M 2025-09
Merck USD 4.15B 102M 2025-09
Moderna USD 267M 92M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
Sanofi EUR 22.93B 2.89B 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Xencor USD 9.08M 9.45M 2025-09


Exelixis Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.